[SYRS] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
20-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -60.11%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 1,982 2,050 1,101 317 317 0 0 -
PBT -75,438 -62,279 -54,010 -47,743 -29,818 -13,431 -8,665 43.40%
Tax 2,550 2,017 -1,527 0 0 0 594 27.47%
NP -75,438 -62,279 -54,010 -47,743 -29,818 -13,431 -9,259 41.83%
Tax Rate - - - - - - - -
Total Cost 77,420 64,329 55,111 48,060 30,135 13,431 9,259 42.44%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -3,806.16 -3,038.00 -4,905.54 -15,060.88 -9,406.31 0.00 0.00 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -18.76 -19.07 -21.26 -37.60 -120.45 -54.25 -84.47 -22.17%
EPS Diluted -18.76 -19.07 -21.26 -37.60 -120.45 -54.25 -84.47 -22.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.